Board of Scientific Counselors, National Center for Injury Prevention and Control, 30709-30710 [2020-10891]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and rechartered under Executive Order
13889 on March 22, 2020, and will
terminate on March 22, 2022.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
SDRR was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters to be Considered: The agenda
will include discussions on the
following dose reconstruction program
quality management and assurance
activities: Dose reconstruction cases
under review from Set 27, possibly
including cases involving, Amchitka
Island Nuclear Explosion Site, Argonne
National Laboratory, Fee Materials
Production Centers (‘‘Fernald Plant’’),
General Electric—Vallecitos, Hanford,
Idaho National Laboratory, Lawrence
Berkeley National Laboratory, Lawrence
VerDate Sep<11>2014
17:51 May 19, 2020
Jkt 250001
Livermore National Laboratory, Nevada
Test Site, Oak Ridge Gaseous Diffusion
Plant (‘‘K–25’’), Office of Science and
Technology Information (‘‘OSTI’’),
Paducah Gaseous Diffusion Plant,
Portsmouth Gaseous Diffusion Plant,
Savannah River Site, Y–12, and
potentially other Department of Energy
and Atomic Weapons Employers
facilities. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–10892 Filed 5–19–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors
(BSC), National Center for Injury
Prevention and Control (NCIPC). This
meeting is open to the public, limited
only by the ports available. There will
be 2,000 telephone ports available.
There will be 40 minutes allotted for
oral public comments at the end of the
open session from 12:20 p.m. to 1:00
p.m. on July 22, 2020.
The public is encouraged to register to
participate by telephone and/or provide
oral public comment using the
registration form available at the link
provided: https://
www.surveymonkey.com/r/NVV9XM2.
Individuals registered to provide oral
public comment will be called upon to
speak based on the order of registration.
After persons who have registered have
spoken, any remaining time in the oral
SUMMARY:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
30709
public comment period will be used for
members of the public who have not
registered to speak but wish to offer
comment. Individuals making oral
public comment during the meeting will
have a 2-minute speaking limit to allow
for as many comments as possible.
DATES: The meeting will be held on July
22, 2020, 10:00 a.m. to 1:00 p.m., EDT
(OPEN) and July 22, 2020, 1:45 p.m. to
4:15 p.m., EDT (CLOSED).
ADDRESSES: Teleconference 1–800–369–
3110; Participant Code 7563795.
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop S106–9, Atlanta,
GA 30341, Telephone (770) 488–3953,
Email address: NCIPCBSC@cdc.gov.
SUPPLEMENTARY INFORMATION: Portions
of the meeting as designated above will
be closed to the public in accordance
with provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Strategic Business Initiatives Unit,
Office of the Chief Operating Officer,
CDC pursuant to Public Law 92–463.
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
BSC, NCIPC makes recommendations
regarding policies, strategies, objectives,
and priorities; reviews progress toward
injury prevention goals; and provides
evidence in injury prevention-related
research and programs. The Board also
provides advice on the appropriate
balance of intramural and extramural
research, as well as the structure,
progress and performance of intramural
programs. The Board is designed to
provide guidance on extramural
scientific program matters, including
the: (1) Review of extramural research
concepts for funding opportunity
announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements,
and contracts applications received in
response to the funding opportunity
announcements as they relate to the
E:\FR\FM\20MYN1.SGM
20MYN1
30710
Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices
Center’s programmatic balance and
mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered
for funding support; (4) review of
research portfolios; and (5) review of
program proposals.
Matters To Be Considered: The open
portion of the agenda will include an
update on the formation of the BSC,
NCIPC Opioid Workgroup, a
presentation focused on opportunities
for stakeholder engagement on
management of acute and chronic pain,
and an update on the CDC Opioid
Prescribing Estimates Project. All
presentations will be followed by
discussion by the BSC. The closed
portion of the agenda will focus on the
secondary peer review of extramural
research grant applications received in
response to two (2) Notice of Funding
Opportunities (NOFOs): RFA–CE20–
001—‘‘Evaluating Practice-Based
Programs, Policies, and Practices from
CDC’s Rape Prevention and Education
(RPE) Program: Expanding the Evidence
to Prevent Sexual Violence’’; and RFA–
CE20–003—‘‘Research Grants for
Preventing Violence and ViolenceRelated Injury’’ (R01). Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–10891 Filed 5–19–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Center for States Evaluation
Ancillary Data Collection (0970–0501)
Children’s Bureau,
Administration on Children, Youth and
Families, Administration for Children
and Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF) is
requesting a 3-year extension of the
collection of information under the
Center for States Evaluation Ancillary
Data Collection (OMB #0970–0501,
expiration date 8/31/2020) without
changes.
SUMMARY:
Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
DATES:
forwarded by emailing infocollection@
acf.hhs.gov. Alternatively, copies can
also be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation (OPRE), 330 C Street
SW, Washington, DC 20201, Attn: ACF
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The Evaluation of the
Child Welfare Capacity Building
Collaborative, Center for States is
sponsored by the Children’s Bureau
(CB), ACF. The purpose of this
evaluation is to respond to a set of crosscutting evaluation questions posed by
CB. This existing information collection
is an ancillary part of a larger data
collection effort being conducted for the
evaluation of the Child Welfare Capacity
Building Collaborative (0970–0484 and
0970–0494). This notice details a group
of instruments that are specific only to
the Center for States. The instruments
focus on (1) evaluating an innovative
approach to engaging professionals in
networking and professional
development through virtual
conferences, (2) understanding fidelity
to and effectiveness of the Center for
States’ Capacity Building Model, and (3)
capturing consistent information during
the updated annual assessment process
focused on related contextual issues
impacting potential service delivery
such as implementation of new
legislation.
Respondents: Respondents of these
data collection instruments will include
child welfare agency staff and
stakeholders who directly receive
services.
ANNUAL BURDEN ESTIMATES
Total number
of respondents
Instrument
Child Welfare Virtual Conference:
Child Welfare Virtual Conference Session Surveys .....
Child Welfare Virtual Conference Focus Group Guide
Child Welfare Virtual Conference Interview Guide .......
Child Welfare Virtual Conference Registration Form ...
Child Welfare Virtual Conference Exit Survey .............
Tailored Services Capacity Building Approach:
Tailored Services Practice Model Survey ....................
Assessment Observation— Group Debrief ..................
Service Delivery and Tracking and Adjustment Observation—Group Debrief ..............................................
Assessment and Service Delivery State Lead Interviews—Supplemental Questions ..............................
Assessment questions:
Annual Assessment Update (8 systematic questions)
Total .......................................................................
VerDate Sep<11>2014
17:51 May 19, 2020
Jkt 250001
PO 00000
Total number
of responses
per
respondent
Average
burden hours
per response
Total burden
hours
Annual burden
hours
450
30
20
1000
225
6
1
1
1
1
.08
1
.5
.03
.16
216
30
10
30
36
72
10
3
10
12
130
50
1
1
.12
.25
15.6
12.5
5
4
80
1
.25
20
7
30
1
.5
15
5
54
1
.08
4.32
1
........................
........................
........................
........................
130
Frm 00029
Fmt 4703
Sfmt 4703
E:\FR\FM\20MYN1.SGM
20MYN1
]]>Agencies
[Federal Register Volume 85, Number 98 (Wednesday, May 20, 2020)]
[Notices]
[Pages 30709-30710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10891]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors
(BSC), National Center for Injury Prevention and Control (NCIPC). This
meeting is open to the public, limited only by the ports available.
There will be 2,000 telephone ports available. There will be 40 minutes
allotted for oral public comments at the end of the open session from
12:20 p.m. to 1:00 p.m. on July 22, 2020.
The public is encouraged to register to participate by telephone
and/or provide oral public comment using the registration form
available at the link provided: https://www.surveymonkey.com/r/NVV9XM2.
Individuals registered to provide oral public comment will be
called upon to speak based on the order of registration. After persons
who have registered have spoken, any remaining time in the oral public
comment period will be used for members of the public who have not
registered to speak but wish to offer comment. Individuals making oral
public comment during the meeting will have a 2-minute speaking limit
to allow for as many comments as possible.
DATES: The meeting will be held on July 22, 2020, 10:00 a.m. to 1:00
p.m., EDT (OPEN) and July 22, 2020, 1:45 p.m. to 4:15 p.m., EDT
(CLOSED).
ADDRESSES: Teleconference 1-800-369-3110; Participant Code 7563795.
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway NE, Mailstop S106-9, Atlanta, GA 30341, Telephone (770)
488-3953, Email address: [email protected].
SUPPLEMENTARY INFORMATION: Portions of the meeting as designated above
will be closed to the public in accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of
the Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, CDC pursuant to Public Law 92-463.
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The BSC, NCIPC makes
recommendations regarding policies, strategies, objectives, and
priorities; reviews progress toward injury prevention goals; and
provides evidence in injury prevention-related research and programs.
The Board also provides advice on the appropriate balance of intramural
and extramural research, as well as the structure, progress and
performance of intramural programs. The Board is designed to provide
guidance on extramural scientific program matters, including the: (1)
Review of extramural research concepts for funding opportunity
announcements; (2) conduct of Secondary Peer Review of extramural
research grants, cooperative agreements, and contracts applications
received in response to the funding opportunity announcements as they
relate to the
[[Page 30710]]
Center's programmatic balance and mission; (3) submission of secondary
review recommendations to the Center Director of applications to be
considered for funding support; (4) review of research portfolios; and
(5) review of program proposals.
Matters To Be Considered: The open portion of the agenda will
include an update on the formation of the BSC, NCIPC Opioid Workgroup,
a presentation focused on opportunities for stakeholder engagement on
management of acute and chronic pain, and an update on the CDC Opioid
Prescribing Estimates Project. All presentations will be followed by
discussion by the BSC. The closed portion of the agenda will focus on
the secondary peer review of extramural research grant applications
received in response to two (2) Notice of Funding Opportunities
(NOFOs): RFA-CE20-001--``Evaluating Practice-Based Programs, Policies,
and Practices from CDC's Rape Prevention and Education (RPE) Program:
Expanding the Evidence to Prevent Sexual Violence''; and RFA-CE20-003--
``Research Grants for Preventing Violence and Violence-Related Injury''
(R01). Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, CDC, has been delegated the authority to sign
Federal Register notices pertaining to announcements of meetings and
other committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and Disease
Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-10891 Filed 5-19-20; 8:45 am]
BILLING CODE 4163-18-P
